Clinical Trials Browser

Phase 1/2 × Melanoma × Gene Expression Profiling × Clear all

NCT00811759 2010-10-07

Sorafenib and Temozolomide in Treating Patients With Stage III or Stage IV Melanoma

Phase 1/2 Unknown

Melanoma